Title: Kevin HAMBLETT, et al. Anti-her2 biparatopic antibody-drug conjugates and methods of use. WO2019173911A1.
1286281-32-0
1446282-18-3
1818294-42-6
209542-49-4
31127-85-2
252881-74-6
848193-69-1 | (R)-6-Chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide | AA00G3O8 | MFCD28291828
78734-79-9 | 2-Chloro-N-(1-cyanocyclohexyl)-N-methylacetamide | AA00G3SI | MFCD05273565
77199-09-8 | Ethyl 5-bromopicolinate | AA00G3YK | MFCD00234415
77444-88-3 | 1-BENZYL-3-METHANESULFONYL-4,5-DIMETHYL-1H-PYRROL-2-YLAMINE | AA00G45M | MFCD05256272
841275-78-3 | 1-Acetyl-2-methylindoline-5-sulphonyl chloride | AA00G4GR | MFCD07841689
857549-15-6 | [(4-Methyl-1,3-thiazol-5-yl)methyl]amine dihydrochloride | AA00G4M1 | MFCD08060724
81165-17-5 | Anhydro Vinblastine Disulfate Salt | AA00G4SY
81176-41-2 | 6-EPI PRAVASTATIN, SODIUM SALT | AA00G4ZJ | MFCD09841202
858515-82-9 | 1-(CyclohexylMethyl)-1H-indole-3-carboxylic Acid Methyl Ester | AA00G57R | MFCD29036757
847996-42-3 | Isoxazolo[5,4-c]pyridin-3(2H)-one | AA00G5MS | MFCD13181755